Presented below are condensed financial statements adapted from those of two actual companies competing in the pharmaceutical industryJohnson and Johnson and Pfizer, Incorporated ($ in millions, except per share amounts). Balance Sheets ($ in millions, except per share data) Johnson and Johnson Pfizer Assets: Cash $ 17,305 $ 1,305 Short-term investments 1,982 8,525 Accounts receivable (net) 14,481 8,724 Inventory 9,020 8,283 Other current assets 2,486 5,966 Current assets 45,274 32,803 Property, plant, and equipment (net) 17,658 13,967 Intangibles and other assets 94,796 120,719 Total assets $ 157,728 $ 167,489 Liabilities and Shareholders' Equity: Accounts payable $ 8,544 $ 4,220 Short-term notes 1,202 16,195 Other current liabilities 26,218 16,8